– Reuters Citing Company Livestream
FDA Approves Abbott’s New Spinal Cord Stimulation Device For Pain
The FDA has approved Abbott Laboratories (NYSE:ABT) new Proclaim Plus spinal cord stimulation (SCS) system featuring FlexBurst360 therapy. The next generation…